Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes

por Yang, Chieh-Hsin, Ann-Onda, Danise, Lin, Xuzhu, Fynch, Stacey, Nadarajah, Shaktypreya, Pappas, Evan G., Liu, Xin, Scott, John W., Oakhill, Jonathan S., Galic, Sandra, Shi, Yanchuan, Moreno-Asso, Alba, Smith, Cassandra, Loudovaris, Thomas, Levinger, Itamar, Eizirik, Decio L., Laybutt, D. Ross, Herzog, Herbert, Thomas, Helen E., Loh, Kim
Publicado 2021